With a decent dose of publicity coming to Microsoft Corp. (NASDAQ:MSFT) these days from the gaming console universe, the world's largest software company has decided to release an upgrade to its vaunted Xbox 360 gaming platform, probably to slap the face of Sony (NYSE:SNE). Sony's current struggle with the PlayStation 3, no matter how its presented, is most likely causing strain to the company and will continue to do so for at least a few quarters.
The new system from Ole' Softie, called the "Xbox 360 Elite," will sell for about $480 and should be in stores by the end of April, according to Microsoft. What has changed? Well, the largest upgrade will be the hard drive inside the new unit, which will come in at 120GB instead of 20GB from the standard Xbox 360. Some gaming fans were wishing for WiFi wireless connectivity and a newer HD DVD player, but no go this time. Microsoft's not putting this new Xbox 360 Elite feature-for-feature against Sony's PlayStation 3 it seems here -- but is that 100% important? Probably not.
More storage for games and faster game access is the priority apparently, which is the direction Microsoft is heading with the new gaming console. Also, with Microsoft under pressure to show a profit from the xbox (and gaming) division, some believe the new "Elite" system is more about appeasing Wall Street than customers. Such is life -- customers get the shaft (but don't they buy the products?) while those market makers get their wishes. In this case, though, ensuring Microsoft does not continue losing money on these consoles is probably a top priority instead of adding top-of-the-line features --- and possibly losing even more money on each system sold.
Last updated: February 10, 2012: 07:01 AM
Hot Stocks
DailyFinance Headlines
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Greek workers launch general strike, NY Times says
- Realty Income downgraded to Sector Perform from Outperform at RBC Capital
- ValueVision renews three TV distribution agreements
- O'Charley's downgraded to Market Perform from Outperform at Morgan Keegan
- Alibaba Group to take private Hong Kong listed unit, Reuters reports
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

